Oral Immunotherapy of Chronic Bronchitis: a Double-Blind Placebo-Controlled Multicentre Study
Authors:
- M. UstarMUM. Ustar
- R. PardonRPR. Pardon
- I. PalecekIPI. Palecek
- A. Stipic-MarkovicASA. Stipic-Markovic
- B. ZimicBZB. Zimic
- 1 January 1989
- journal article
- research article
- Published by S. Karger AG in Respiration
- Vol. 55 (3) , 129-135
Abstract
104 patients with chronic bronchitis were treated under randomized double-blind conditions with either Broncho-Vaxom (BV) or a placebo over a period of 6 consecutive months. The beneficial effect of BV was manifested by a statistically significant reduction in the duration of acute episodes and of fever (p less than 0.001) with respect to the placebo group. The consumption of antibiotics dropped significantly in the BV group (p less than 0.05) but not in the placebo group. The serum IgA levels increased in the BV group and the difference with the placebo group was statistically significant (p less than 0.05) from the 3rd month onwards. In the patients with bronchitic exacerbations during the trial, T-lymphocyte counts increased steadily under BV therapy until 3 months after the exacerbation (p less than 0.05), but not under the placebo. BV was generally well tolerated with the exception of 1 patient who reported nausea and upper abdominal pain. In their assessment of the overall therapeutic effect, the physician judged BV to be significantly superior (p less than 0.001) to the placebo as regards both the curative and prophylactic efficacy.Keywords
This publication has 3 references indexed in Scilit:
- Immunomodulation of allergic autocytotoxicity in bronchial asthma by a bacterial lysate — Broncho-VaxomRInternational Journal of Immunopharmacology, 1985
- The anatomy of peripheral lymphoid organs with emphasis on accessory cells: Light‐microscopic immunocytochemical studies of mouse spleen, lymph node, and peyer's patchJournal of Anatomy, 1984
- Immunoglobulin Production in Man Stimulated by an Orally Administered Bacterial LysateRespiration, 1980